Trasylol Not Associated With Renal/Heart Failure, MI, Stroke, Cmte. Says
FDA’s Cardiovascular & Renal Drugs Advisory Committee reiterate risk of renal dysfunction associated with aprotinin at its Sept. 21 meeting.
FDA’s Cardiovascular & Renal Drugs Advisory Committee reiterate risk of renal dysfunction associated with aprotinin at its Sept. 21 meeting.